Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 "Rescue" techniques in cancer chemotherapy: use of leucovorin and other rescue agents after methotrexate treatment.

× No keyword cloud information.

17 in total

1. Alleviation by leucovorin of the dose-limiting toxicity of edatrexate: potential for improved therapeutic efficacy.

Authors: J S Lee; W K Murphy; M H Shirinian; A Pang; W K Hong
Journal: Cancer Chemother Pharmacol Date: 1991 Impact factor: 3.333

2. [High-dose methotrexate therapy in osteogenic sarcoma: plasma pharmakokinetics to predict toxicity (author's transl)].

Authors: G E Janka; H Wiesner; F Bidlingmaier; R J Haas
Journal: Klin Wochenschr Date: 1979-04-17

3. Pharmacokinetic monitoring of high-dose methotrexate. Early recognition of high-risk patients.

Authors: W E Evans; C B Pratt; R H Taylor; L F Barker; W R Crom
Journal: Cancer Chemother Pharmacol Date: 1979 Impact factor: 3.333

4. High-dose methotrexate with citrovorum factor rescue in non-small-cell lung cancer.

Authors: F A Greco; M F Fer; R L Richardson; K R Hande; C J Van Boxtel; R K Oldham
Journal: Cancer Chemother Pharmacol Date: 1978 Impact factor: 3.333

5. Long-duration intracavitary infusion of methotrexate with systemic leucovorin protection in patients with malignant effusions.

Authors: S B Howell; B B Chu; W E Wung; B M Metha; J Mendelsohn
Journal: J Clin Invest Date: 1981-04 Impact factor: 14.808

"Rescue" techniques in cancer chemotherapy: use of leucovorin and other rescue agents after methotrexate treatment.

1. Alleviation by leucovorin of the dose-limiting toxicity of edatrexate: potential for improved therapeutic efficacy.

2. [High-dose methotrexate therapy in osteogenic sarcoma: plasma pharmakokinetics to predict toxicity (author's transl)].

3. Pharmacokinetic monitoring of high-dose methotrexate. Early recognition of high-risk patients.

4. High-dose methotrexate with citrovorum factor rescue in non-small-cell lung cancer.

5. Long-duration intracavitary infusion of methotrexate with systemic leucovorin protection in patients with malignant effusions.

Review 6. The practical use of methotrexate in psoriasis.

Review 7. Pharmacokinetics of anticancer drugs in children.

8. Differential calcium leucovorin protection of human lymphoid cell lines from methotrexate.

9. Methotrexate and methotrexate polyglutamates in human sarcoma metastases after high-dose methotrexate therapy.

10. Comparison of leucovorin protection from variety of antifolates in human lymphoid cell lines.